Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-020385·Harraden Circle Investments, LLC
Schedule 13G ownership disclosure
PSYENCE BIOMEDICAL LTD
Class A Common Stock · CUSIP: 74449F209
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Harraden Circle Investments, LLC
Shares: 182,323 · Class: 5.32%
- Harraden Circle Investors GP, LP
Shares: 182,323 · Class: 5.32%
- Harraden Circle Investors GP, LLC
Shares: 182,323 · Class: 5.32%
- Harraden Circle Investors, LP
Shares: 91,162 · Class: 2.66%
- Harraden Circle Special Opportunities, LP
Shares: 91,161 · Class: 2.66%
- Frederick V. Fortmiller, Jr.
Shares: 182,323 · Class: 5.32%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020385
- Form type
- SCHEDULE 13G/A
- Filer
- Harraden Circle Investments, LLC
- CIK
- CIK 1910592
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership